Lindsay A Md Rosenwald Checkpoint Therapeutics, Inc. (CKPT) insider trading activity

Lindsay A Md Rosenwald is Director of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CKPT, which is worth approximately $0. The most recent transaction as insider was on May 30, 2025, when has been sold 207,007 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

LINDSAY A MD ROSENWALD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	207,007 Reduced 100.0%	0 Common Stock
May 29 2025	BUY Grant, award, or other acquisition	$64,500 $1.29 p/Share	50,000 Added 19.45%	207,007 Common Stock
May 28 2025	BUY Grant, award, or other acquisition	-	12,195 Added 7.21%	157,007 Common Stock
Dec 13 2024	BUY Grant, award, or other acquisition	-	12,638 Added 8.03%	144,812 Common Stock
May 14 2024	BUY Grant, award, or other acquisition	-	82,051 Added 38.3%	132,174 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	17,483 Added 25.86%	50,123 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	47,619 Added 12.73%	326,401 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	-	16,502 Added 5.59%	278,782 Common Stock

Also insider at

FBIO

Fortress Biotech, Inc. Healthcare

PRESIDENT, CEO & CHAIRMAN

DERM

Journey Medical Corp Healthcare

Director

MBIO

MUSTANG BIO, INC. Healthcare

Director

ATXI

AVENUE THERAPEUTICS, INC. Healthcare

Director

LAM